Active Ingredient History

  • Now
Apricoxib is an experimental anticancer drug and nonsteroidal anti-inflammatory drug (NSAID). It is a COX-2 inhibitor which is intended to improve standard therapy response in molecularly-defined models of pancreatic cancer. It was also studied in clinical trials for non-small-cell lung cancer. Development was abandoned in 2015 due to poor clinical trial results.   Wikipedia

  • SMILES: CCOc1ccc(cc1)c2cc(C)cn2c3ccc(cc3)S(=O)(=O)N
  • Mol. Mass: 356.45
  • ALogP: 3.5
  • ChEMBL Molecule:
More Chemistry
2-(4-ethoxyphenyl)-4-methyl 1-(4-sulfamoylphenyl)-1h-pyrrole | apricoxib | cs 706 | cs-706 | cs706 cpd | r-109339 | tg01


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue